Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-30 4:04 pm Purchase |
2022-08-22 | 13G | Health Catalyst, Inc. HCAT |
MILLENNIUM MANAGEMENT LLC | 2,830,788 5.200% |
2,830,788 (New Position) |
Filing History |
| 2022-08-10 09:34 am Purchase |
2022-07-29 | 13G | Health Catalyst, Inc. HCAT |
The Vanguard Group | 5,492,511 10.140% |
1,209,772 (+28.25%) |
Filing History |
| 2022-06-10 11:04 am Sale |
2022-06-09 | 13G | Health Catalyst, Inc. HCAT |
FMR CORP | 194,897 0.358% |
-2,917,127 (-93.74%) |
Filing History |
| 2022-04-11 09:01 am Sale |
2022-04-08 | 13G | Health Catalyst, Inc. HCAT |
FMR CORP | 3,112,024 5.815% |
-4,373,386 (-58.43%) |
Filing History |
| 2022-02-14 4:31 pm Purchase |
2022-02-14 | 13G | Health Catalyst, Inc. HCAT |
ALLIANCE CAPITAL MANAGEMENT L P | 3,085,813 6.000% |
3,085,813 (New Position) |
Filing History |
| 2022-02-11 12:22 pm Purchase |
2022-02-14 | 13G | Health Catalyst, Inc. HCAT |
Capital Research Global Investors | 3,392,000 6.500% |
509,300 (+17.67%) |
Filing History |
| 2022-02-10 08:16 am Purchase |
2021-12-31 | 13G | Health Catalyst, Inc. HCAT |
The Vanguard Group | 4,282,739 8.230% |
1,398,107 (+48.47%) |
Filing History |
| 2022-02-09 09:19 am Purchase |
2022-02-08 | 13G | Health Catalyst, Inc. HCAT |
FMR CORP | 7,485,410 14.363% |
2,602,358 (+53.29%) |
Filing History |
| 2022-02-04 09:17 am Purchase |
2021-12-31 | 13G | Health Catalyst, Inc. HCAT |
WELLINGTON MANAGEMENT CO LLP | 3,622,171 6.960% |
656,268 (+22.13%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Health Catalyst, Inc. HCAT |
BLACKROCK INC BLK |
4,699,392 9.000% |
179,736 (+3.98%) |
Filing History |
| 2021-07-12 08:29 am Purchase |
2021-06-30 | 13G | Health Catalyst, Inc. HCAT |
BLACKROCK INC BLK |
4,519,656 10.200% |
1,988,256 (+78.54%) |
Filing History |
| 2021-04-12 1:05 pm Purchase |
2021-04-09 | 13G | Health Catalyst, Inc. HCAT |
FMR CORP | 4,883,052 11.072% |
2,682,743 (+121.93%) |
Filing History |
| 2021-02-16 3:11 pm Purchase |
2021-02-16 | 13G | Health Catalyst, Inc. HCAT |
Capital Research Global Investors | 2,882,700 6.800% |
2,882,700 (New Position) |
Filing History |
| 2021-02-12 8:50 pm Unchanged |
2020-12-31 | 13G | Health Catalyst, Inc. HCAT |
SC US (TTGP), LTD. ("SC US (TTGP)") | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-12 5:06 pm Sale |
2020-12-31 | 13G | Health Catalyst, Inc. HCAT |
Norwest Venture Partners XI LP | 0 0.000% |
-5,904,181 (Position Closed) |
Filing History |
| 2021-02-10 10:57 am Purchase |
2020-12-31 | 13G | Health Catalyst, Inc. HCAT |
The Vanguard Group | 2,884,632 6.790% |
2,884,632 (New Position) |
Filing History |
| 2021-02-08 10:23 am Purchase |
2021-02-05 | 13G | Health Catalyst, Inc. HCAT |
FMR CORP | 2,200,309 5.165% |
8,490 (+0.39%) |
Filing History |
| 2021-02-04 09:37 am Purchase |
2020-12-31 | 13G | Health Catalyst, Inc. HCAT |
WELLINGTON MANAGEMENT CO LLP | 2,965,903 6.980% |
2,965,903 (New Position) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Health Catalyst, Inc. HCAT |
BLACKROCK INC BLK |
2,531,400 6.000% |
2,531,400 (New Position) |
Filing History |
| 2021-01-11 10:51 am Purchase |
2021-01-08 | 13G | Health Catalyst, Inc. HCAT |
FMR CORP | 2,191,819 5.145% |
2,191,819 (New Position) |
Filing History |